A global solution and removing barriers to antibiotic development are necessary to combat antimicrobial resistance (AMR). Representatives from various research and health sectors discussed strategies for fighting superbugs at a BIO International Convention super session today. The panel agreed there must be a greater focus on streamlining clinical trials and harmonizing the global regulatory process to support the development of new antibiotics. Jim O'Neill, chairman, Review on Antimicrobial Resistance, recommended the establishment of a global $2 billion AMR Innovation Fund over five years funded by industry to help jump start product development. Venture capitalist risk could stimulate...
Tags21st Century Cures advocacy Advocacy Awards AHRQ appropriations biomedical research Campaign for Cures cancer CDC continuing resolution COVID-19 FDA global health health research innovation Mary Woolley medical research mental health National Health Research Forum NIH NSF public health Public Health Thank You Day research Research!America science sequestration supplemental funding weekly letter weekly message
How Can I Help?
Other Advocacy Tools:
If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana